This review is an attempt to illustrate the co-relation between inflammatory cytokines (such as IL-6, TNF alpha and IL-1), angiogenic markers (such as VEGF and TGFβ), apoptotic markers (such as Bax and caspase-3) and their relation to bone protection (OPG and RANKL). It also shows the role of each in rheumatoid arthritis (RA) progression. As the pathogenesis of RA depends on massive inflammation and neovascularization.
Rheumatoid arthritis (RA) is a chronic and progressive autoimmune inflammatory disease associated with irreversible joint destruction which leads to permanent motor disability and compromised quality of life. It carries essential or real burden on the patient or individual and the society. The patient burden comes from joints destruction and deficits that lead to decline in daily physical function, comorbidities risks and finally quality of life. While, the economic burden on the society results from medical costs and decreased work capacity due to disability (McInnes and Schett, 2011).
The incidence of rheumatoid arthritis is 0.5 -1 %. This incidence may be differ from rural and urban areas. It also may decrease from north to south. According to the World Health Organization (WHO), RA predominantly strikes during the most productive years of adulthood and within 10 years of its onset, more than half of RA patients in developed countries lose their full-time jobs (Briggs et al., 2016).
The main cause of RA is unknown till now, although a lot of factors could be involved in its occurrence or trigger its mechanism of development such as susceptibility genes, environmental factors (smoking, low socioeconomic status and low educational attainment) in addition to alcohol consumption. Moreover, microbiomes (microbial populations in oral, salivary and GIT sites) are associated with CRP level and may be involved in triggering of RA (Barton and Worthington, 2009; Carlens et al., 2010).
Rheumatoid arthritis affects the joints mainly the synovium of joint. Cartilage destruction and bone erosion develop during late stages of RA after occurrence of synovitis, synovial hyperplasia, pannus formation, stiffness and joint swelling (Kotake et al., 1996; Maeno et al., 2004; McInnes and Schett, 2011; Briggs et al., 2016) . In conjunction with its articular manifestations, RA patients usually suffer from coexisting autoimmune hepatitis and splenomegaly. RA also affects other organs as lung, skeletal muscles and heart However, several pro-inflammatory cytokines are involved in RA development, IL-6 is the key inflammatory mediator in RA (2012; Tanaka et al., 2012). IL-6 is a proinflammatory cytokine with a pleiotropic activity. IL-6 is produced from different/various immune cells like/such as synovocytes (synovial fibroblastic cells) in response to synovocytes stimulation/activation by different/ various cytokines like TNF, IL-17 and IL-1 or (others) in response to infection, trauma and immunological challenges (Kotake et al., 1996; Palmqvist et al., 2002; Hashizume and Mihara, 2011) . IL-6 has multiple/ many functions depending on its signaling pathway where it binds with two types of receptors: membrane bound Il-6 receptor (mIL-6R) and soluble IL-6 receptor (sIL-6R) which lacks/ loses its intracytoplasmic portion of mIL-6R ( Beside alongside its effect/action on osteoclast, IL-6 enhances/improves angiogenesis (formation of new blood vessels from existing ones) and vascular permeability of synovial tissue through/via inducting/inducing production of vascular endothelial growth factor (VEGF) from synovial fibroblast (Nakahara et al., 2003). VEGF is also produced secondary to/in response to simulation/ activation by TGFβ (FraterSchroder et al., 1987). Synovial angiogenesis contributes to/ participates in maintenance of inflammation and progression of RA (Maruotti et al., 2006 , 1993) . Serum concentrations of VEGF also correlate with serum levels of C-reactive protein (CRP) that is considered as an inflammatory biomarker/factor in RA and produced from hepatocytes secondary to/ in response to stimulation/activation by IL-6, so it is produced at the early stage of the disease and its concentrations correlate with severity of the RA (Paleolog and Miotla, 1998). Moreover, VEGF contributes/relates to the proliferation of synovial tissues. Neovascularization/angiogenesis permits/allows infiltration of more and more inflammatory cells that worse the disease state (Maruotti et al., 2006) .
On the other hand, Apoptosis has a role in most auto-immune disease. Apoptosis is a programmed cell death type I (PCD). It is involved in both physiological and pathological process. It participates in normal cell turnover, proper development and functioning of immune system. Inadequate or Inappropriate apoptosis is correlated to several diseases/pathologies such as neurodegenerative disease and autoimmune disorders. Apoptosis occurs normally during growth/development and aging. It also has homeostatic role/mechanism to maintain/preserve cell populations in tissues. Sometimes It occurs as a defense mechanism in secondary to/ response to immune response/ immunological reactions or cellular destruction caused/induced by disease or harmful agents (Norbury and Hickson, 2001).
Apoptosis composed/consists of two pathways, one of both is intrinsic pathway and other is extrinsic pathway (Fig. 3) . The extrinsic pathway of apoptosis initiates or starts apoptosis via transmembrane receptor-mediated interactions (Fig. 3) . These include or involve death receptors which are considered members of the tumor necrosis factor (TNF) receptor gene superfamily On the other hand, the intrinsic pathway mainly depends on cytochrome c which released from intermembrane space of mitochondria into cytoplasm of the cell after Bax and Bak aggregation on the mitochondrial membrane and forming BH123 channel that allows/ permits release of cytochrome c (Saelens et al., 2004) . In this pathway cytochrome c is triggering apoptosis via/through activation of caspases (caspase cascade reaction). Caspases are widely expressed in form of an inactive proenzyme in majority of cells. After that it can activate other procaspases which lead to amplification of the apoptotic signaling pathway and finally leading to rapid cell death. Aggregation of Bax/Bak that cause changing in permeability of mitochondrial membrane. This process can be controlled and regulated by the Bcl-2 family of proteins (Cory and Adams, 2002). The Bcl-2 family can be either pro-apoptotic such as Bax or anti-apoptotic such as Bcl-2, Bcl-X, and Bcl-Xs.
In RA, there is a relationship between angiogenic cytokines, bone erosion markers and apoptosis process. So, apoptosis (apoptotic process) participates in RA pathophysiology. TGFβ increases apoptosis in the synovium (Firestein et al., 1995) . Furthermore, RANKL induces apoptosis of osteoblasts (Goldring, 2003). Heightened and lessened activity of apoptotic machinery have been both reported (Catrina et al., 2002) . During early stage of RA, apoptosis is inhibited resulting in rapid cell proliferation along with increasing cellular influx from blood into the synovium (Firestein et al., 1995) . This increases cytokines production and inflammation resulting in hyperplasia, the prominent feature of RA. In contrast, later stage of RA is characterized by intensified apoptosis secondary to increased expression of p53, a critical regulator of synovial fibroblast like cell proliferation, apoptosis and invasiveness (Tak et al., 2000a; Tak et al., 2000b; Dhaouadi  et al., 2007) . Remarkably, p53 overexpression was observed in cultured fibroblast like synovocytes derived from RA patients. Western blot analysis and immunoprecipitation studies also confirmed the high levels of p53 protein in RA synovium compared with forms of arthritis. Another study showed that characteristic DNA ladders were found in DNA isolated from whole RA synovial tissues, suggesting that apoptosis occurs in inflamed synovium (Tak et al., 2000a) . Apoptosis also correlated with RA severity (Catrina et al.,  2002) . This is in accordance with Paul et al., (Tak et al., 2000a) who has reported that apoptosis was increased in late stage RA adjuvant induced arthritis model. Furthermore, it has been shown that T-cells in rheumatoid synovial expressed low Bcl-2, high Bax and High Fas, a phenotype that suggests increased susceptibility of T-cells to apoptosis.
While using, apoptosis inducing agents may be useful in early stage of RA to overcome the rapid proliferation of cells and inhibit recruitment of inflammatory cells in RA synovium, the continuous apoptotic effect and/or further apoptosis induction aggravate bone erosion. Accordingly, the use of anti-apoptotic therapeutic agent or apoptosis inducing agent must be linked with the disease stage.
Conclusion:
There is a strong correlation between inflammatory, angiogenesis, apoptotic markers and their relation with bone protection/erosion (Fig. 4) 
